- South Korean study investigated oncologic outcomes of BCT vs. mastectomy in breast cancer patients with BRCA1 or BRCA2 pathogenic variants.
- Included 575 female patients with a median follow-up of 8.3 years.
- No significant differences in oncologic outcomes between BCT and mastectomy groups.
- BCT considered a safe and effective option, offering comparable long-term outcomes to mastectomy.
- Further prospective studies recommended for confirmation of findings.
Source: JAMA Network Open
